Social Pulse: Pacira Pharmaceuticals Inc (PCRX.OQ)
PCRX.OQ on NASDAQ Stock Exchange Global Select Market
34.11USD
1 Aug 2013
34.11USD
1 Aug 2013
Price Change (% chg)
$0.18 (+0.53%)
$0.18 (+0.53%)
Prev Close
$33.93
$33.93
Open
$34.36
$34.36
Day's High
$34.43
$34.43
Day's Low
$33.90
$33.90
Volume
142,415
142,415
Avg. Vol
115,784
115,784
52-wk High
$35.86
$35.86
52-wk Low
$14.46
$14.46
- Here's Why Pacira Pharmaceuticals's Latest Report Might Worry You
- 2 Healthcare Companies With Recent Intensive Insider Selling
- FDA Accepts New Drug Application And Creates A Catalyst For Durect Corporation
- 5 Buy Signals From the Health Care Sector
- SALT 2013: The 5 Best Ideas of the Year Ahead
- Pacira Pharmaceuticals' CEO Discusses Q1 2013 Results - Earnings Call Transcript
Press Releases
- New Publication Suggests Higher Opioid Use in the Postsurgical Setting May Be Linked to Extended Hospital Stay and Increased Cost of Care
- Pacira Pharmaceuticals, Inc. and Aratana Therapeutics Inc. Enter into Global Licensing Agreement for Development and Commercialization of Bupivacaine Liposome Injectable Suspension for Animal Health Indications
- New Data Demonstrate Reduction in Opioid Use, Hospital Cost and Length of Stay with EXPAREL as the Foundation of a Multimodal Regimen
- Pacira Pharmaceuticals, Inc. to Present at the 24th Annual Piper Jaffray Healthcare Conference
- New Data Supporting Use of EXPAREL via Infiltration into the Transversus Abdominis Plane Presented at 11th Annual American Society of Regional Anesthesia and Pain Medicine Meeting

